ANVI Global Holdings Announces 1-for-20 Reverse Stock Split

What Happened

• ANVI Global Holdings, Inc. (ticker: ANVI) filed an 8-K reporting that a holder of 72,000,000 shares (approximately 60.03% of the 119,950,000 issued and outstanding shares) executed a Written Consent on September 4, 2026, approving an amendment to the Articles of Incorporation to effect a 1-for-20 reverse stock split. The Board had approved and recommended the reverse split on August 29, 2026.
• The reverse split is not yet effective — it is subject to SEC Schedule 14C clearance, FINRA approval, and the requirement that a Definitive Information Statement be mailed and at least 20 calendar days elapse before the split can become mechanically effective.

Key Details

• Reverse split ratio: 1-for-20 (each 20 pre-split shares → 1 post-split share).
• Outstanding shares before split: 119,950,000; estimated outstanding shares after split (if all shares are included): ~5,997,500.
• Stockholder consent date: September 4, 2026; Board resolution date: August 29, 2026.
• OTCQB deficiency: On June 6, 2026 OTC Markets notified ANVI that its minimum closing bid fell below $0.01 for 30 consecutive days; initial cure deadline set for October 5, 2026. The company requested a 60‑day cure extension from OTC Markets and notified FINRA of the corporate action.
• Management had considered injecting an exploration mining asset to raise the bid price but could not complete the transfer due to technical and regional geopolitical delays, prompting the pivot to a reverse split.

Why It Matters

• The reverse split is a common, legal method to raise a stock’s per-share trading price to meet listing standards (here, the OTCQB $0.01 minimum). If approved by SEC/FINRA and implemented, it could help ANVI regain or maintain OTCQB compliance and avoid a downgrade to the OTC Pink market, per the filing.
• The action changes the number of shares outstanding and the per-share price but does not, in itself, change the company’s underlying value or the proportional ownership of shareholders (aside from the handling of fractional shares).
• Investors should note the transaction remains conditional on regulatory clearances and the Schedule 14C mailing/notice periods — it is not yet final.